Green Mountain Coffee Roasters Inc GMCR rose 29.93% to $56.70 in the pre-market session. GMCR agreed to sell Starbucks Corp's SBUX coffee and Tazo teas pods for its popular Keurig machines.
Human Genome Sciences Inc HGSI added 8.41% to $27.84 in the pre-market session. GlaxoSmithKline Plc GSK and HGSI received the Food and Drug Administration (FDA) approval for Benlysta, the first new drug to treat lupus in over 50 years.
Starbucks Corp SBUX moved up 6.49% to $36.78 in the pre-market session. Green Mountain Coffee Roasters Inc agreed to sell SBUX's coffee and Tazo teas pods for its popular Keurig machines.
Atrinsic Inc ATRN soared 4.03% to $4.39 in the pre-market trading. ATRN had $4.25 million in total cash and no debt for the latest quarter.
Read more from Benzinga's Markets.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
